Results showed a 77% survival rate in patients below 50 years who used carboplatin, an increase from the 66% without it ...

This scary Halloween cake looks just like a real brain-oozing details and all—but it’s 100% edible and surprisingly delicious. A must-bake for spooky season. ‘Dumisani Khumalo and co-accused are very ...

The special video shows that the love of the "Peanuts" gang has made it through generations of the Schulz family Charles M. Schulz Museum/Instagram; Alamy It has been 75 years since the "Peanuts" ...

aDepartment of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan bDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of ...

Attorney General Pam Bondi pledges to go after "hate speech," saying there's no place for it after Charlie Kirk’s assassination. But that isn't U.S. law under the First Amendment, and Kirk himself ...

Contact: Chris Martin, MPH IASLC Media Relations [email protected] (Barcelona, Spain September 7, 2025, 10:45 a.m. CEST / UTC +2) – New results from the ACROSS 2 Phase III trial demonstrate ...

Abstract: Since acquiring perfect supervision is usually difficult, real-world machine learning tasks often confront inaccurate, incomplete, or inexact supervision, collectively referred to as weak ...

Adding everolimus to carboplatin was associated with significantly increased progression-free survival (PFS) among patients with advanced triple-negative breast cancer (TNBC), according to a recent ...

Clinical Pharmacology Adaptive Therapy group, Division of Clinical Studies and Division of Cancer Therapeutics, Institute of Cancer Research, London SM2 5NG, United Kingdom Clinical Pharmacology ...

Founded by former OpenAI staff members and funded by Amazon and Google, Anthropic has raised the stakes in the GPT wars. Anthropic's Claude Desktop app often outshines its ChatGPT rival in various ...

Panelists discuss how current NCCN guidelines for metastatic anal cancer recommend carboplatin-paclitaxel as preferred first-line therapy, with the recent addition of carboplatin-paclitaxel plus ...